Background: The VITEK® 2 is a new version of the automated system for organism identification and susceptibility testing. One of the differences between this system and its predecessor, VITEK, is the ability to perform rapid susceptibility testing of Streptococcus pneumoniae. This study compares the results of susceptibility testing of S. pneumoniae using the VITEK 2 system and a commercial microbroth dilution method, Sensititre. Methods: A group of 214 clinical isolates of S. pneumoniae were selected to include isolates with previously documented penicillin resistance. The antimicrobial agents tested were benzylpenicillin, cefotaxime, erythromycin, trimethoprim/sulfamethoxazole, tetracycline, chloramphenicol, imipenem and vancomycin. Results: The best agreement was achieved with vancomycin (100%), erythromycin (95.8%) and tetracycline (95.8%). The lowest level of agreement was found with benzylpenicillin (88.6%) and cefotaxime (90.1%). We observed rates of 12.3 and 15.7% for minor errors with penicillin and cefotaxime, respectively, and 1 very major error for cefotaxime. Conclusion: The VITEK 2 allows rapid determination of the antimicrobial susceptibility of S. pneumoniae and demonstrated a good degree of agreement with the Sensititre method for most of the antimicrobials tested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.